Clinical Evaluation for Medical Devices
Support at every step; from scoping and literature review to submission-ready CERs
Clinical Evaluation Documentation Suite
Our Clinical Evaluation Document Suite delivers integrated EU MDR compliance with a comprehensive State-of-the-Art report (SotA), Clinical Evaluation Plan (CEP), and Clinical Evaluation Report (CER).
Tailored to your device's risk classification and clinical context, this end-to-end solution ensures consistent, compliant documentation with Annex XIV, MDCG & other international guidance, and streamlines Notified Body interactions.
Clinical Evidence Gap Analysis & Remediation Planning
We assess existing documentation against MDR Annexes to identify gaps in clinical evidence and provide actionable remediation strategies, helping you avoid Notified Body nonconformities.
Clinical Evaluation Strategy Development
We develop regulatory strategies for clinical evaluation (MDR) that align with Annex XIV and MDCG guidance, ensuring your evidence generation roadmap meets Notified Body expectations and supports your technical documentation.
Clinical Investigation Support
We provide regulatory and operational guidance for clinical investigations (MDR), including protocol development, submission support, and oversight through Ethics Committee and Competent Authority approval.
State-of-the-Art Reports
We deliver defensible state of the art (SotA) reports that position your device within the clinical landscape, supporting benefit-risk justification and performance claims.
Clinical Evaluation Plan Authoring
We prepare structured, regulator-ready CEP documents to demonstrate proactive planning and compliance with EU regulatory requirements, supporting a smooth CE marking process.
Systematic Literature Review and Appraisal
Our rigorous systematic literature reviews (SLRs) meet the methodological standards for inclusion in your CER, enhancing the quality and traceability of your clinical evidence.
Clinical Evaluation Report Authoring
Our expert-led writing of CERs meet the stringent requirements of MDR, combining literature data, real-world evidence, and robust benefit-risk analysis for regulatory submission.